Across the US, half of all adults live with a chronic disease – and many of them are prescribed a self-injectable therapy to help manage their condition. As the patient population and demand for self-injection treatments continue to grow, so will the number of patients being introduced to self-injection drug delivery devices. This growing trend increases the importance of effective training and the onboarding process (the first 30-90 days of treatment) as more patients find themselves self-managing their treatments away from clinics.
Published on